Published in Biochem Cell Biol on January 01, 1987
Functional role of human immunodeficiency virus type 1 vpu. Proc Natl Acad Sci U S A (1989) 5.72
Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc Natl Acad Sci U S A (1993) 3.63
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med (2001) 2.83
Mutational analysis of the 5' non-coding region of human immunodeficiency virus type 1: effects of secondary structure on translation. EMBO J (1988) 2.65
The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. J Virol (1995) 2.64
The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J Virol (1994) 2.22
Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles. J Virol (1994) 2.20
Myonecrosis after revascularization procedures. J Am Coll Cardiol (1998) 2.11
The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells. EMBO J (1997) 2.10
Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J Virol (1995) 2.09
Envelope glycoprotein and CD4 independence of vpu-facilitated human immunodeficiency virus type 1 capsid export. J Virol (1992) 2.05
Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells. J Virol (1998) 1.97
Fairness in the coronary angiography queue. CMAJ (1999) 1.83
Results of the Prospective Evaluation of Radial Keratotomy (PERK) Study 4 years after surgery for myopia. Perk Study Group. JAMA (1990) 1.63
Polarized human immunodeficiency virus budding in lymphocytes involves a tyrosine-based signal and favors cell-to-cell viral transmission. J Virol (1999) 1.61
Failed coronary stent deployment. Am Heart J (1998) 1.60
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators. N Engl J Med (1999) 1.55
Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects. Cancer Res (2000) 1.55
A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med (1993) 1.55
The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation. J Virol (2000) 1.50
Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French-Canadian founder population. Am J Med Genet (1999) 1.49
Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages. J Exp Med (1998) 1.49
Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.47
Molecular biology of the human immunodeficiency virus accessory proteins. J Virol (1994) 1.44
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial. J Thromb Haemost (2005) 1.42
Sulphated glycoproteins induced by herpes simplex virus. J Gen Virol (1982) 1.40
Human immunodeficiency virus type 1 (HIV-1) Vpr functions as an immediate-early protein during HIV-1 infection. J Virol (1999) 1.37
Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality. CMAJ (2000) 1.36
Characterization of ribonucleotide reductase induction in BHK-21/C13 Syrian hamster cell line upon infection by herpes simplex virus (HSV). J Gen Virol (1981) 1.35
HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator. Proc Natl Acad Sci U S A (1998) 1.35
cDNA sequence and homologies of the "57-kDa" nucleotide-binding subunit of the vacuolar ATPase from Arabidopsis. J Biol Chem (1988) 1.34
Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2. Nature (1986) 1.33
Structural and functional analysis of the membrane-spanning domain of the human immunodeficiency virus type 1 Vpu protein. Virology (1998) 1.33
Identification of distinct messenger RNAs for nuclear lamin C and a putative precursor of nuclear lamin A. J Cell Biol (1984) 1.32
Incorporation of Vpr into human immunodeficiency virus type 1 requires a direct interaction with the p6 domain of the p55 gag precursor. J Biol Chem (1999) 1.28
The effect of vpu on HIV-1-induced syncytia formation. J Acquir Immune Defic Syndr (1993) 1.25
Inducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette. J Virol (1998) 1.25
Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA). Circulation (1999) 1.21
Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved. J Mol Biol (1998) 1.19
Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression. J Virol (2000) 1.17
RNA trafficking signals in human immunodeficiency virus type 1. Mol Cell Biol (2001) 1.13
Identification of a proliferation-related transcript with an elevated expression in the mid-gestation mouse embryo. Biochim Biophys Acta (1988) 1.12
Two distinct oncornaviruses harbor an intracytoplasmic tyrosine-based basolateral targeting signal in their viral envelope glycoprotein. J Virol (1997) 1.12
The role of the tnv protein and tnv RNA splicing signals in replication of HIV-1 IIIB isolates. Virology (1992) 1.11
Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.10
Human immunodeficiency virus type 1 Vpr localization: nuclear transport of a viral protein modulated by a putative amphipathic helical structure and its relevance to biological activity. J Mol Biol (1998) 1.09
Improved adenovirus vector provides herpes simplex virus ribonucleotide reductase R1 and R2 subunits very efficiently. Biotechnology (N Y) (1995) 1.09
Neuronal discharges of the ventrolateral nucleus of the thalamus during sleep and wakefulness in the cat. I. Spontaneous activity. Exp Brain Res (1971) 1.09
Aanlysis of dCMP deaminase and CDP reductase levels in hamster cells infected by herpes simplex virus. J Virol (1978) 1.08
Retracted Human immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A. EMBO J (2000) 1.08
Nonfunctioning nonchromaffin paraganglioma of the pancreas. Arch Surg (1974) 1.06
A PCR-denaturing gradient gel electrophoresis approach to assess Fusarium diversity in asparagus. J Microbiol Methods (2005) 1.04
Predictors of improvement in left ventricular function after percutaneous revascularization of occluded coronary arteries: a report from the Total Occlusion Study of Canada (TOSCA). Am Heart J (2001) 1.02
New adenovirus vectors for protein production and gene transfer. Cytotechnology (1998) 1.01
Parallel processing in the basal ganglia: up to a point. Trends Neurosci (1991) 0.99
Responses of ponto-medullary reticular neurons to cortical, tectal and cutaneous stimuli. Exp Brain Res (1974) 0.99
Immunoprecipitation of polypeptides from hamster embryo cells transformed by herpes simplex virus type 2. Virology (1980) 0.99
Physiopathology of experimental Parkinsonism in the monkey. Can J Neurol Sci (1975) 0.99
Systematic bias in the reporting of angioplasty outcomes: accuracy of visual estimates of absolute lumen diameters. Can J Cardiol (1994) 0.99
Localization of sulfated glycoprotein-2/clusterin mRNA in the rat brain by in situ hybridization. J Comp Neurol (1993) 0.98
Poststroke depression and emotional incontinence: factors related to acute and subacute stages. Neurology (2012) 0.97
Quantification of Fusarium solani f. sp. phaseoli in Mycorrhizal Bean Plants and Surrounding Mycorrhizosphere Soil Using Real-Time Polymerase Chain Reaction and Direct Isolations on Selective Media. Phytopathology (2003) 0.97
Herpes simplex virus ribonucleotide reductase induced in infected BHK-21/C13 cells: biochemical evidence for the existence of two non-identical subunits, H1 and H2. J Gen Virol (1985) 0.96
Cerebellar flocculus and paraflocculus Purkinje cell activity during circular pursuit in monkey. J Neurophysiol (2000) 0.95
Depurinating and stable benzo[a]pyrene-DNA adducts formed in isolated rat liver nuclei. Chem Res Toxicol (1997) 0.95
Putative alpha-helical structures in the human immunodeficiency virus type 1 Vpu protein and CD4 are involved in binding and degradation of the CD4 molecule. J Virol (1997) 0.95
Human gliomas and epileptic foci express high levels of a mRNA related to rat testicular sulfated glycoprotein 2, a purported marker of cell death. Proc Natl Acad Sci U S A (1991) 0.94
Effect of docosahexaenoic acid supplementation on retinal function in a patient with autosomal dominant Stargardt-like retinal dystrophy. Br J Ophthalmol (2004) 0.94
Characterization of the cytotoxic factor(s) released from thymic dendritic cells upon human immunodeficiency virus type 1 infection. Virology (1998) 0.93
Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction. Am Heart J (2001) 0.93
Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3*0101 and HLA-DQB1*0201. Hum Immunol (1992) 0.92
Analysis of chromosomes, nucleic acids, and polypeptides in hamster cells transformed by herpes simplex virus type 2. Cancer Res (1979) 0.92
HCV core protein modulates Rb pathway through pRb down-regulation and E2F-1 up-regulation. Biochim Biophys Acta (2001) 0.92
The deltaF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells. J Nutr (2000) 0.92
Degradation of CD4 induced by human immunodeficiency virus type 1 Vpu protein: a predicted alpha-helix structure in the proximal cytoplasmic region of CD4 contributes to Vpu sensitivity. Virology (1995) 0.92
Neuronal discharges of the ventrolateral nucleus of the thalamus during sleep and wakefulness in the cat. II. Evoked activity. Exp Brain Res (1971) 0.91
Affinity purification of active subunit 1 of herpes simplex virus type 1 ribonucleotide reductase exhibiting a protein kinase activity. J Biol Chem (1991) 0.91
Organization of the sunflower 11S storage protein gene family. Gene (1988) 0.91
Responses of pallidal neurons to striatal stimulation in monkeys with MPTP-induced parkinsonism. Brain Res (1989) 0.91
HIV-1 HxBc2 strain encodes a truncated vpr gene product of 78 amino acids. J Acquir Immune Defic Syndr (1993) 0.90
Progressive increase of motor activity induced by 5-HTP in the rat below a complete secretion of the spinal cord. Brain Res (1979) 0.90
In vitro interaction of the carboxy-terminal domain of lamin A with actin. FEBS Lett (1998) 0.90
High level expression in 293 cells of the herpes simplex virus type 2 ribonucleotide reductase subunit 2 using an adenovirus vector. J Gen Virol (1990) 0.89
Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harboured by a leptomeningeal cell line from a patient with multiple sclerosis. J Gen Virol (1993) 0.89
Quantified EEG changes associated with a positive clinical response to clozapine in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (1995) 0.89
The conversion of some biochemical properties of mammalian skeletal muscles following cross-reinnervation. Exp Neurol (1977) 0.89
Sequence and expression of a gene encoding an albumin storage protein in sunflower. Mol Gen Genet (1987) 0.88
Effects of Vpu expression on Xenopus oocyte membrane conductance. Virology (1998) 0.88
Distinct afferents to internal and external pallidal segments in the squirrel monkey. Neurosci Lett (1989) 0.88
Responses of pallidal neurons to striatal stimulation in intact waking monkeys. Brain Res (1989) 0.88
A two-tier polymerase chain reaction direct sequencing method for detecting and typing human papillomaviruses in pathological specimens. Diagn Mol Pathol (1998) 0.87
Protein synthesis in pox-infected cells treated with interferon. Virology (1972) 0.87
Molecular analysis of the cytoplasmic domain of CD4: overlapping but noncompetitive requirement for lck association and down-regulation by Nef. J Immunol (1996) 0.87
Increased mutation frequency after herpes simplex virus type 2 infection in non-permissive XC cells. J Gen Virol (1985) 0.86
Streptozotocin-induced diabetes in rats is associated with impaired metabolic availability of vitamin A (retinol). Br J Nutr (1996) 0.86